Overview

  • Product namePapaverine
  • Description
    Potent PDE inhibitor
  • Alternative names
    • NSC 136630
  • Biological descriptionPotent PDE inhibitor. Partially selective for PDE10A (IC50 = 36 nM, 9-fold over other PDE isoforms). Inhibits cAMP and cGMP on smooth muscle cells causing vasodilation. Disrupts the blood-brain barrier causing increased cerebral blood flow.
  • Purity> 98%

Properties

    References for Papaverine (ab120942)

    This product has been referenced in:
    • Zhang Z  et al. Synthesis and in vitro evaluation of new analogues as inhibitors for phosphodiesterase 10A. Eur J Med Chem 46:3986-95 (2011). Read more (PubMed: 21705115) »
    • Platz J  et al. Disruption of the blood-brain barrier by intra-arterial administration of papaverine: a technical note. Neuroradiology 50:1035-9 (2008). Read more (PubMed: 18791708) »
    • Zhao Y  et al. Inhibitor binding to type 4 phosphodiesterase (PDE4) assessed using [3H]piclamilast and [3H]rolipram. J Pharmacol Exp Ther 305:565-72 (2003). Read more (PubMed: 12704225) »

    See 0 Publications for this product

    Product Wall

    There are currently no Abreviews or Questions for ab120942.
    Please use the links above to contact us or submit feedback about this product.

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE, NOT FOR USE IN HUMANS"